Half Yearly Results Results Snapshot
Figures in Cr
Standalone Half Yearly Results
Sep'25
Dec'24
Sep'24
Dec'23
Dec'22
Dec'21
Dec'20
Half Yearly Analysis Highlights
Net Sales
Growth in half year ended Sep 2025 is 11.11%
Standalone Net Profit
Growth in half year ended Sep 2025 is 56.11%
Operating Profit (PBDIT) excl Other Income
Growth in half year ended Sep 2025 is 29.77%
Interest
Growth in half year ended Sep 2025 is -31.43%
Operating Profit Margin (Excl OI)
Growth in half year ended Sep 2025 has improved from Sep 2024
Compare Half Yearly Results Of P & G Health Ltd With
Figures in Cr
Standalone Half Yearly Results
Change(INR)
Change(%)
Net Sales
663.66
366.45
297.21
81.11%
Other Operating Income
0.00
0.00
0.00
Total Operating income
663.66
366.45
297.21
81.11%
Raw Material Cost
137.67
222.43
-84.76
-38.11%
Purchase of Finished goods
34.95
0.96
33.99
3,540.62%
(Increase) / Decrease In Stocks
-10.23
7.99
-18.22
-228.04%
Employee Cost
109.89
45.66
64.23
140.67%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.01
100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
180.77
75.91
104.86
138.14%
Total Expenditure (Excl Depreciation)
453.05
352.94
100.11
28.36%
Operating Profit (PBDIT) excl Other Income
210.61
13.51
197.10
1,458.92%
Other Income
8.98
31.36
-22.38
-71.36%
Operating Profit (PBDIT)
219.59
44.87
174.72
389.39%
Interest
0.24
6.99
-6.75
-96.57%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
219.35
37.88
181.47
479.07%
Depreciation
11.52
17.45
-5.93
-33.98%
Profit Before Tax
207.83
20.43
187.40
917.28%
Tax
53.11
0.00
53.11
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
154.72
20.43
134.29
657.32%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
154.72
20.43
134.29
657.32%
Equity Capital
16.60
50.72
-34.12
-67.27%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
93.20
4.03
89.17
2,212.66%
Diluted Earnings per share
93.21
4.03
89.18
2,212.90%
Operating Profit Margin (Excl OI)
31.73%
3.69%
0.00
28.04%
Gross Profit Margin
33.05%
10.34%
0.00
22.71%
PAT Margin
23.31%
5.58%
0.00
17.73%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 663.66 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 11.11%
Half Yearly - Standalone Net Profit
Standalone Net Profit 154.72 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 56.11%
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 210.61 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 29.77%
Half Yearly - Interest
Interest 0.24 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is -31.43%
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 31.73%
in Sep 2025Figures in %
Growth in half year ended Sep 2025 has improved from Sep 2024
